Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients

MLA

Zachary Simmons, et al. “Tocilizumab Is Safe and Tolerable and Reduces C-Reactive Protein Concentrations in the Plasma and Cerebrospinal Fluid of ALS Patients.” Musclenerve, vol. 64, no. 3, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....221ba7e6ae6e103a8620dd02d37bb32c&authtype=sso&custid=ns315887.

APA

Zachary Simmons, Shafeeq Ladha, Robert Bowser, James Caress, Merit Cudkowicz, Suma Babu, Carol Milligan, Richard J. Barohn, Marlena Wosiski-Kuhn, Nazem Atassi, Jeremy M. Shefner, Gregory A. Hawkins, Armineuza Evora, & Eric A. Macklin. (2021). Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients. Musclenerve, 64(3).

Chicago

Zachary Simmons, Shafeeq Ladha, Robert Bowser, James Caress, Merit Cudkowicz, Suma Babu, Carol Milligan, et al. 2021. “Tocilizumab Is Safe and Tolerable and Reduces C-Reactive Protein Concentrations in the Plasma and Cerebrospinal Fluid of ALS Patients.” Musclenerve 64 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....221ba7e6ae6e103a8620dd02d37bb32c&authtype=sso&custid=ns315887.